Background The role of immunotherapy in the treatment of locally advanced head and neck squamous cell carcinoma (LA HNSCC) remains uncertain, particularly in cases of unresectable LA HNSCC. This meta-
Mean values (IQR) of ISDs trough concentrations and biomarker expression levels for patients who presented AR and patients who did not from week 1 to month 1.
Localized scleroderma (LS), also known as morphea, is an idiopathic immune-mediated inflammatory and sclerosing disease with cutaneous and extracutaneous manifestations. Early treatment initiation is
Associations between immune responses and SHIV infection risk were assessed by lasso-penalized Cox regression in all vaccinated animals with sex, vaccine arm, and all peak (month 12.5) immunogenicity
